Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    May 2019
  1. EDO N, Kawakami K, Fujita Y, Morita K, et al
    Exosomes expressing thyrotropin receptor ameliorate autoantibody-mediated stimulation of cyclic adenosine monophosphate production.
    Thyroid. 2019 May 7. doi: 10.1089/thy.2018.0772.
    PubMed     Text format     Abstract available


    April 2019
  2. HAN SY, Choi SH, Shin JS, Lee EJ, et al
    HMGB1 is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Thyroid. 2019 Apr 11. doi: 10.1089/thy.2018.0285.
    PubMed     Text format     Abstract available


  3. GRULET H, Barraud S, Chikh K, Souchon PF, et al
    Three consecutive pregnancies in a patient with chronic autoimmune thyroid disease associated with hypothyroidism and extremely high levels of anti-TSH receptor antibodies.
    Thyroid. 2019 Apr 11. doi: 10.1089/thy.2018.0098.
    PubMed     Text format     Abstract available


  4. HAN C, He X, Xia X, Guo J, et al
    Sphk1/S1P/S1PR1 signaling is involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2h4 Mice.
    Thyroid. 2019 Apr 9. doi: 10.1089/thy.2018.0065.
    PubMed     Text format     Abstract available


    March 2019
  5. MALMSTROEM S, Grove-Laugesen D, Riis AL, Bruun BJ, et al
    Muscle performance and postural stability are reduced in patients with newly diagnosed Graves' disease.
    Thyroid. 2019 Mar 18. doi: 10.1089/thy.2018.0318.
    PubMed     Text format     Abstract available


  6. DRAMAN MS, Morris D, Evans S, Haridas A, et al
    PROSTAGLANDIN F2-ALPHA EYE DROPS (BIMATOPROST) IN GRAVES' ORBITOPATHY: A RANDOMISED CONTROLLED DOUBLE MASKED CROSSOVER TRIAL (BIMA TRIAL).
    Thyroid. 2019 Mar 18. doi: 10.1089/thy.2018.0506.
    PubMed     Text format     Abstract available


    February 2019
  7. SCHRIJVER B, Kooiman MA, Kasteleijn E, van Holten-Neelen C, et al
    BASIC FIBROBLAST GROWTH FACTOR INDUCES ADIPOGENESIS IN ORBITAL FIBROBLASTS; IMPLICATION FOR THE PATHOGENESIS OF GRAVES' ORBITOPATHY.
    Thyroid. 2019 Feb 6. doi: 10.1089/thy.2018.0544.
    PubMed     Text format     Abstract available



  8. Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, Butter
    Thyroid. 2019;29:309.
    PubMed     Text format    


    January 2019
  9. EDMUNDS MR, Boelaert K
    Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Thyroid. 2019 Jan 28. doi: 10.1089/thy.2018.0665.
    PubMed     Text format     Abstract available


  10. FASSBENDER J, Holthoff HP, Li Z, Ungerer M, et al
    Therapeutic effects of short cyclic and combined epitope peptides in a long-term model of Graves disease and orbitopathy.
    Thyroid. 2019 Jan 8. doi: 10.1089/thy.2018.0326.
    PubMed     Text format     Abstract available


    November 2018
  11. YOSHIHARA A, Iwaku K, Noh JY, Watanabe N, et al
    Incidence of neonatal hyperthyroidism among newborns of Graves' disease patients treated with radioiodine therapy.
    Thyroid. 2018 Nov 14. doi: 10.1089/thy.2018.0165.
    PubMed     Text format     Abstract available


  12. WANG W, Mao J, Zhao J, Lu J, et al
    Decreased Thyroid Peroxidase Antibody Titer in Response to Selenium Supplementation in Autoimmune Thyroiditis and the Influence of a SEPP Gene Polymorphism: A Prospective, Multicenter study in China.
    Thyroid. 2018 Nov 6. doi: 10.1089/thy.2017.0230.
    PubMed     Text format     Abstract available


    October 2018
  13. MARCINKOWSKI P, Hoyer I, Specker E, Furkert J, et al
    A new highly thyrotropin receptor-selective small molecule antagonist with potential for the treatment of Graves' orbitopathy.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0349.
    PubMed     Text format     Abstract available


  14. MULLER I, Willis M, Healy S, Nasser T, et al
    Longitudinal characterization of autoantibodies to the thyrotropin receptor (TRAb) during alemtuzumab therapy; evidence that TRAb may precede thyroid dysfunction by many years.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0232.
    PubMed     Text format     Abstract available


  15. DEKKER B, van der Horst-Schrivers ANA, Sluiter WJ, Brouwers AH, et al
    The clinical applicability of low levels of thyroglobulin autoantibodies (TgAbs) as cut-off point for TgAb positivity.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0195.
    PubMed     Text format     Abstract available


    June 2018
  16. KOREVAAR T, Minguez-Alarcon L, Messerlian C, de Poortere R, et al
    The association of thyroid function and autoimmunity with ovarian reserve in women seeking infertility care.
    Thyroid. 2018 Jun 26. doi: 10.1089/thy.2017.0582.
    PubMed     Text format     Abstract available


    April 2018
  17. MARCUS-SAMUELS B, Krieger CC, Boutin A, Kahaly G, et al
    Evidence that Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.
    Thyroid. 2018 Apr 10. doi: 10.1089/thy.2018.0089.
    PubMed     Text format     Abstract available


  18. MCLACHLAN SM, Rapoport B
    A Role for Satb1 in Thyroid Autoimmunity?
    Thyroid. 2018 Apr 5. doi: 10.1089/thy.2017.0713.
    PubMed     Text format    


    March 2018
  19. HAN YE, Hwang S, Kim JH, Byun JW, et al
    Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Thyroid. 2018 Mar 28. doi: 10.1089/thy.2017.0338.
    PubMed     Text format     Abstract available


  20. GUO Q, Wu D, Yu H, Bao J, et al
    Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
    Thyroid. 2018;28:377-385.
    PubMed     Text format     Abstract available


    February 2018
  21. LATROFA F, Ricci D, Bottai S, Brozzi F, et al
    Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0052.
    PubMed     Text format     Abstract available


    January 2018
  22. YANG X, Lun Y, Jiang H, Liu X, et al
    SIRT1-regualted abnormal acetylation of FOXP3 induces Treg function defect in Hashimoto's thyroiditis.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0286.
    PubMed     Text format     Abstract available


  23. PAPADAKIS GE, Lamine F, Chtioui H, Moschouri E, et al
    Rapid remission of Graves' hyperthyroidism without thionamides under immunosuppressive treatment for concomitant autoimmune hepatitis.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0613.
    PubMed     Text format     Abstract available


  24. SABINI E, Mazzi B, Profilo MA, Mautone T, et al
    SERUM HIGH CHOLESTEROL IS A NOVEL RISK FACTOR FOR GRAVES' ORBITOPATHY (GO): RESULTS OF A CROSS-SECTIONAL STUDY.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0430.
    PubMed     Text format     Abstract available


  25. VAN DIJK MM, Smits I, Fliers E, Bisschop PH, et al
    Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: A systematic review.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0413.
    PubMed     Text format     Abstract available


  26. ZHAO F, Feng J, Li J, Zhao L, et al
    Alterations of the gut microbiota in Hashimoto's thyroiditis patients.
    Thyroid. 2018 Jan 10. doi: 10.1089/thy.2017.0395.
    PubMed     Text format     Abstract available


    November 2017
  27. WATANABE M, Takenaka Y, Honda C, Twin Research Group O, et al
    Genotype-based epigenetic differences in monozygotic twins discordant for positive anti-thyroglobulin autoantibodies.
    Thyroid. 2017 Nov 4. doi: 10.1089/thy.2017.0273.
    PubMed     Text format     Abstract available


    October 2017
  28. YANG J, Yao LP, Dong M, Xu Q, et al
    Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with Graves' disease: A median 38-month retrospective cohort study from a single institution in China.
    Thyroid. 2017 Oct 31. doi: 10.1089/thy.2017.0468.
    PubMed     Text format     Abstract available


  29. FERLOV-SCHWENSEN C, Brix TH, Hegedus L
    Death by suicide in Graves' disease and Graves' orbitopathy. A nationwide Danish register study.
    Thyroid. 2017 Oct 30. doi: 10.1089/thy.2017.0365.
    PubMed     Text format     Abstract available


  30. HASHIMOTO K, Nishihara E, Matsumoto M, Matsumoto S, et al
    Sialic acid-binding immunoglobulin-like lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease -A multicenter study.
    Thyroid. 2017 Oct 17. doi: 10.1089/thy.2017.0244.
    PubMed     Text format     Abstract available


    September 2017
  31. GERSHENGORN MC
    No direct evidence for IGF-1 receptor (IGF-1R) stimulating antibodies in Graves' orbitopathy.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


    August 2017
  32. CHEN CW, Huang YL, Huang RL, Tzeng CR, et al
    Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibody.
    Thyroid. 2017 Aug 16. doi: 10.1089/thy.2017.0139.
    PubMed     Text format     Abstract available


  33. YU SH, Kang JG, Kim CS, Ihm SH, et al
    Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0126.
    PubMed     Text format     Abstract available


    July 2017
  34. SWEGAL WC, Chang SS, Singer MC
    Referral Trends for Surgical Management of Graves' Disease.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0145.
    PubMed     Text format     Abstract available


  35. TORIMOTO K, Okada Y, Nakayamada S, Kubo S, et al
    Anti-PD-1 antibody therapy induces Hashimoto's disease with increase in peripheral blood follicular helper T cells.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0062.
    PubMed     Text format     Abstract available


  36. AL-MAJDOUB M, Lantz M, Spegel P
    Treatment of Swedish Patients with Graves' Hyperthyroidism is Associated with Changes in Acylcarnitine Levels.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0218.
    PubMed     Text format     Abstract available


    June 2017
  37. HAIDER U, Richards P, Gianoukakis A
    Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.
    Thyroid. 2017 Jun 3. doi: 10.1089/thy.2017.0086.
    PubMed     Text format     Abstract available


    May 2017
  38. CHEN Y, Chen Y, Xia F, Wang N, et al
    A Higher Ratio of Estradiol to Testosterone is associated with Autoimmune Thyroid Disease in Males.
    Thyroid. 2017 May 30. doi: 10.1089/thy.2016.0661.
    PubMed     Text format     Abstract available


  39. GIESECKE P, Rosenqvist M, Frykman V, Friberg L, et al
    Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2017.0029.
    PubMed     Text format     Abstract available


    April 2017
  40. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  41. LIU T, Sun J, Wang Z, Yang W, et al
    Changes in the DNA methylation and hydroxymethylation status of the intercellular adhesion molecule 1 gene promoter in thyrocytes from autoimmune thyroiditis patients.
    Thyroid. 2017 Apr 7. doi: 10.1089/thy.2016.0576.
    PubMed     Text format     Abstract available


  42. KIM YA, Cho SW, Choi HS, Moon S, et al
    The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
    Thyroid. 2017;27:491-496.
    PubMed     Text format     Abstract available


    March 2017
  43. LI C, Peng S, Liu X, Han C, et al
    Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling.
    Thyroid. 2017 Mar 31. doi: 10.1089/thy.2016.0432.
    PubMed     Text format     Abstract available


    January 2017
  44. SUNDARESH V, Brito JP, Thapa P, Bahn RS, et al
    Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism - A Historical Cohort Study.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0343.
    PubMed     Text format     Abstract available


    September 2016
  45. WU T, Mester T, Gupta S, Sun F, et al
    TSH and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for pathogenesis of Thyroid Associated Ophthalmopathy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  46. TETI C, Nazzari E, Galletti M, Mandolfino MG, et al
    Unexpected elevated free thyroid hormones in pregnancy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  47. CRAMON P, Winther KH, Watt T, Bonnema SJ, et al
    Quality of life impairments persist six months after treatment of Graves' hyperthyroidism and toxic nodular goiter: A prospective cohort study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: